BioLife Solutions Announces COO to Retire and Join Board of Directors
BOTHELL, Wash., Oct. 3, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy ("CGT") and broader biopharma markets, today announced changes to its Board of Directors and executive management team, all to be effective as of January 3, 2023.
- Roderick de Greef, BioLife President and Chief Operating Officer, will retire from management and will re-join the Board of Directors, increasing the number of Directors to seven.
- I'm pleased to report the product line is now stable, with orders shipping from current inventory and record-high overall product quality.
- BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets.
- For more information, please visit www.biolifesolutions.com , www.scisafe.com , www.stirlingultracold.com , or www.sextonbio.com and follow BioLife on Twitter .